 |
市場調査レポート
商品コード
1293752
吸入・点鼻スプレーのジェネリック医薬品市場：適応症別、年齢層別、クラス別、ルート別、流通経路別-2023-2030年の世界予測Inhalation & Nasal Sprays Generic Drugs Market by Indication, Age Group, Class, Route, Distrubution Channel - Russia Ukraine Conflict and High Inflation - Global Forecast 2023-2030 |
||||||
● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。 詳細はお問い合わせください。
価格
| 吸入・点鼻スプレーのジェネリック医薬品市場：適応症別、年齢層別、クラス別、ルート別、流通経路別-2023-2030年の世界予測 |
|
出版日: 2023年06月12日
発行: 360iResearch
ページ情報: 英文 196 Pages
納期: 即日から翌営業日
|
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
- 全表示
- 概要
- 図表
- 目次
概要
吸入・点鼻スプレーのジェネリック医薬品の世界市場は、2023年に80億9,064万米ドル、CAGR 8.60%で大きく成長し、2030年には144億3,272万米ドルに達すると予測されています。
FPNVポジショニング・マトリックス
FPNVポジショニングマトリックスは世界の吸入・点鼻スプレーのジェネリック医薬品市場を評価するために不可欠です。事業戦略と製品満足度の主要指標を調査することで、ベンダーの包括的な評価を提供し、ユーザーは特定のニーズに基づいた情報をもとに意思決定を行うことができます。この高度な分析により、ベンダーは成功の度合いが異なる4つの象限に整理されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。
市場シェア分析
市場シェア分析では、特定の市場領域におけるベンダーの現状を洞察することができます。全体的な収益、顧客基盤、その他の主要指標に対するベンダーの貢献度を比較することで、企業が市場シェアを争う際に、自社の業績や直面している状況をより深く理解することができます。また、本分析では、調査した基準年において、特定のセクターがどの程度競合しているのか、蓄積、断片化の優位性、合併の特徴についても明らかにしています。
本レポートは、以下のポイントに関する洞察を提供します：
1.市場の浸透度：主要企業が提供する市場に関する包括的な情報を提供します。
2.市場の発展：有利な新興市場に関する詳細情報を提供し、市場の成熟セグメントにおける浸透度を分析します。
3.市場の多様化：新製品の上市、未開発地域、最近の開発、投資に関する詳細情報を提供します。
4.市場の動向：ロシア・ウクライナ紛争、高インフレに関する包括的な理解を提供します。
5.競合の評価と情報：主要企業の市場シェア、戦略、製品、認証、規制状況、特許状況、製造能力を網羅的に評価します。
6.製品開発およびイノベーション：将来技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。
本レポートは、以下のような質問にお答えします：
1.吸入・点鼻スプレーのジェネリック医薬品の世界市場規模および予測は？
2.予測期間中、世界の吸入・点鼻スプレーのジェネリック医薬品市場を形成するCOVID-19の阻害要因と影響は？
3.吸入・点鼻スプレーのジェネリック医薬品の世界市場において予測期間中に投資すべき製品/セグメント/アプリケーション/分野は？
4.吸入・点鼻スプレーのジェネリック医薬品の世界市場における競争戦略は？
5.吸入・点鼻スプレーのジェネリック医薬品の世界市場における技術動向と規制の枠組みは？
6.吸入・点鼻スプレーのジェネリック医薬品の世界市場における主要ベンダーの市場シェアは？
7.吸入・点鼻スプレーのジェネリック医薬品の世界市場への参入には、どのような形態や戦略的な動きが適していると考えられるか？
目次
第1章 序文
第2章 調査手法
第3章 エグゼクティブサマリー
第4章 市場の概要
第5章 市場洞察
- 市場力学
- 促進要因
- ジェネリック処方薬の低コスト
- 呼吸器疾患の有病率の増加
- 小児用ネブライザーの大幅な導入
- 抑制要因
- ジェネリック医薬品に対する厳しい規制
- 機会
- 大ヒット医薬品の特許満了とFDA承認の増加
- 製薬会社の研究開発投資が拡大
- 課題
- セグメント内に複数のプレーヤーが存在すること別価格設定圧力
- 促進要因
- 市場動向
- COVID-19の累積的な影響
- ロシア・ウクライナ紛争の累積的影響
- 高インフレの累積的影響
- ポーターのファイブフォース分析
- バリューチェーンとクリティカルパス分析
- 規制の枠組み
- 顧客のカスタマイズ
- 製剤と送達デバイスの変更
第6章 吸入・点鼻スプレーのジェネリック医薬品市場適応症別
- アレルギー性鼻炎
- 喘息
- COPD
第7章 吸入・点鼻スプレーのジェネリック医薬品市場：年齢層別
- 大人
- 2歳から5歳までの子供
- 6歳から12歳までの子供
第8章 吸入・点鼻スプレーのジェネリック医薬品市場クラス別
- アレルギーブロッカー
- 抗コリン作用
- 抗ヒスタミン薬
- 充血除去剤
- マスト細胞阻害剤
- 点鼻ステロイド
第9章 吸入・点鼻スプレーのジェネリック医薬品市場路線別
- 吸入
- 点鼻薬
- トロピカルローション
第10章 吸入・点鼻スプレーのジェネリック医薬品市場販売チャネル別
- 病院医療店
- オンライン薬局
- 薬局小売
第11章 南北アメリカの吸入・点鼻スプレーのジェネリック医薬品市場
- アルゼンチン
- ブラジル
- カナダ
- メキシコ
- 米国
第12章 アジア太平洋地域の吸入・点鼻スプレーのジェネリック医薬品市場
- オーストラリア
- 中国
- インド
- インドネシア
- 日本
- マレーシア
- フィリピン
- シンガポール
- 韓国
- 台湾
- タイ
- ベトナム
第13章 欧州・中東・アフリカの吸入・点鼻スプレーのジェネリック医薬品市場
- デンマーク
- エジプト
- フィンランド
- フランス
- ドイツ
- イスラエル
- イタリア
- オランダ
- ナイジェリア
- ノルウェー
- ポーランド
- カタール
- ロシア
- サウジアラビア
- 南アフリカ
- スペイン
- スウェーデン
- スイス
- トルコ
- アラブ首長国連邦
- 英国
第14章 競合情勢
- FPNVポジショニングマトリクス
- 市場シェア分析：主要企業別
- 競合シナリオ分析：主要企業別
第15章 掲載企業一覧
第16章 付録
- ディスカッションガイド
- ライセンスと価格について
図表
LIST OF FIGURES
- FIGURE 1. INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET RESEARCH PROCESS
- FIGURE 2. INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, 2022 VS 2030
- FIGURE 3. INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
- FIGURE 4. INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY INDICATION, 2022 VS 2030 (%)
- FIGURE 5. INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY AGE GROUP, 2022 VS 2030 (%)
- FIGURE 6. INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY CLASS, 2022 VS 2030 (%)
- FIGURE 7. INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY ROUTE, 2022 VS 2030 (%)
- FIGURE 8. INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY DISTRUBUTION CHANNEL, 2022 VS 2030 (%)
- FIGURE 9. INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY REGION, 2022 VS 2030 (%)
- FIGURE 10. INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET DYNAMICS
- FIGURE 11. INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY INDICATION, 2022 VS 2023 VS 2030 (USD MILLION)
- FIGURE 12. INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY AGE GROUP, 2022 VS 2023 VS 2030 (USD MILLION)
- FIGURE 13. INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY CLASS, 2022 VS 2023 VS 2030 (USD MILLION)
- FIGURE 14. INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY ROUTE, 2022 VS 2023 VS 2030 (USD MILLION)
- FIGURE 15. INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY DISTRUBUTION CHANNEL, 2022 VS 2023 VS 2030 (USD MILLION)
- FIGURE 16. AMERICAS INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
- FIGURE 17. UNITED STATES INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
- FIGURE 18. ASIA-PACIFIC INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
- FIGURE 19. EUROPE, MIDDLE EAST & AFRICA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
- FIGURE 20. INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET, FPNV POSITIONING MATRIX, 2022
- FIGURE 21. INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SHARE, BY KEY PLAYER, 2022
LIST OF TABLES
- TABLE 1. INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SEGMENTATION & COVERAGE
- TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
- TABLE 3. INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
- TABLE 4. INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
- TABLE 5. INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY ALLERGIC RHINITIS, BY REGION, 2018-2030 (USD MILLION)
- TABLE 6. INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY ASTHMA, BY REGION, 2018-2030 (USD MILLION)
- TABLE 7. INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY COPD, BY REGION, 2018-2030 (USD MILLION)
- TABLE 8. INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
- TABLE 9. INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY ADULTS, BY REGION, 2018-2030 (USD MILLION)
- TABLE 10. INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY CHILDREN 2 TO 5, BY REGION, 2018-2030 (USD MILLION)
- TABLE 11. INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY CHILDREN 6 TO 12, BY REGION, 2018-2030 (USD MILLION)
- TABLE 12. INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
- TABLE 13. INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY ALLERGY BLOCKER, BY REGION, 2018-2030 (USD MILLION)
- TABLE 14. INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY ANTICHOLINERGIC, BY REGION, 2018-2030 (USD MILLION)
- TABLE 15. INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY ANTIHISTAMINE, BY REGION, 2018-2030 (USD MILLION)
- TABLE 16. INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY DECONGESTANT, BY REGION, 2018-2030 (USD MILLION)
- TABLE 17. INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY MAST CELL INHIBITOR, BY REGION, 2018-2030 (USD MILLION)
- TABLE 18. INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY NASAL STEROID, BY REGION, 2018-2030 (USD MILLION)
- TABLE 19. INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY ROUTE, 2018-2030 (USD MILLION)
- TABLE 20. INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY INHALATION, BY REGION, 2018-2030 (USD MILLION)
- TABLE 21. INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY NASAL SPRAY, BY REGION, 2018-2030 (USD MILLION)
- TABLE 22. INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY TROPICAL LOTION, BY REGION, 2018-2030 (USD MILLION)
- TABLE 23. INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY DISTRUBUTION CHANNEL, 2018-2030 (USD MILLION)
- TABLE 24. INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY HOSPITAL MEDICAL STORE, BY REGION, 2018-2030 (USD MILLION)
- TABLE 25. INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2030 (USD MILLION)
- TABLE 26. INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY PHARMACY RETAIL, BY REGION, 2018-2030 (USD MILLION)
- TABLE 27. AMERICAS INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
- TABLE 28. AMERICAS INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
- TABLE 29. AMERICAS INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
- TABLE 30. AMERICAS INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
- TABLE 31. AMERICAS INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY ROUTE, 2018-2030 (USD MILLION)
- TABLE 32. AMERICAS INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY DISTRUBUTION CHANNEL, 2018-2030 (USD MILLION)
- TABLE 33. ARGENTINA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
- TABLE 34. ARGENTINA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
- TABLE 35. ARGENTINA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
- TABLE 36. ARGENTINA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY ROUTE, 2018-2030 (USD MILLION)
- TABLE 37. ARGENTINA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY DISTRUBUTION CHANNEL, 2018-2030 (USD MILLION)
- TABLE 38. BRAZIL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
- TABLE 39. BRAZIL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
- TABLE 40. BRAZIL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
- TABLE 41. BRAZIL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY ROUTE, 2018-2030 (USD MILLION)
- TABLE 42. BRAZIL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY DISTRUBUTION CHANNEL, 2018-2030 (USD MILLION)
- TABLE 43. CANADA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
- TABLE 44. CANADA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
- TABLE 45. CANADA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
- TABLE 46. CANADA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY ROUTE, 2018-2030 (USD MILLION)
- TABLE 47. CANADA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY DISTRUBUTION CHANNEL, 2018-2030 (USD MILLION)
- TABLE 48. MEXICO INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
- TABLE 49. MEXICO INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
- TABLE 50. MEXICO INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
- TABLE 51. MEXICO INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY ROUTE, 2018-2030 (USD MILLION)
- TABLE 52. MEXICO INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY DISTRUBUTION CHANNEL, 2018-2030 (USD MILLION)
- TABLE 53. UNITED STATES INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
- TABLE 54. UNITED STATES INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
- TABLE 55. UNITED STATES INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
- TABLE 56. UNITED STATES INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
- TABLE 57. UNITED STATES INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY ROUTE, 2018-2030 (USD MILLION)
- TABLE 58. UNITED STATES INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY DISTRUBUTION CHANNEL, 2018-2030 (USD MILLION)
- TABLE 59. ASIA-PACIFIC INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
- TABLE 60. ASIA-PACIFIC INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
- TABLE 61. ASIA-PACIFIC INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
- TABLE 62. ASIA-PACIFIC INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
- TABLE 63. ASIA-PACIFIC INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY ROUTE, 2018-2030 (USD MILLION)
- TABLE 64. ASIA-PACIFIC INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY DISTRUBUTION CHANNEL, 2018-2030 (USD MILLION)
- TABLE 65. AUSTRALIA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
- TABLE 66. AUSTRALIA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
- TABLE 67. AUSTRALIA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
- TABLE 68. AUSTRALIA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY ROUTE, 2018-2030 (USD MILLION)
- TABLE 69. AUSTRALIA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY DISTRUBUTION CHANNEL, 2018-2030 (USD MILLION)
- TABLE 70. CHINA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
- TABLE 71. CHINA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
- TABLE 72. CHINA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
- TABLE 73. CHINA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY ROUTE, 2018-2030 (USD MILLION)
- TABLE 74. CHINA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY DISTRUBUTION CHANNEL, 2018-2030 (USD MILLION)
- TABLE 75. INDIA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
- TABLE 76. INDIA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
- TABLE 77. INDIA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
- TABLE 78. INDIA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY ROUTE, 2018-2030 (USD MILLION)
- TABLE 79. INDIA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY DISTRUBUTION CHANNEL, 2018-2030 (USD MILLION)
- TABLE 80. INDONESIA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
- TABLE 81. INDONESIA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
- TABLE 82. INDONESIA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
- TABLE 83. INDONESIA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY ROUTE, 2018-2030 (USD MILLION)
- TABLE 84. INDONESIA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY DISTRUBUTION CHANNEL, 2018-2030 (USD MILLION)
- TABLE 85. JAPAN INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
- TABLE 86. JAPAN INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
- TABLE 87. JAPAN INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
- TABLE 88. JAPAN INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY ROUTE, 2018-2030 (USD MILLION)
- TABLE 89. JAPAN INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY DISTRUBUTION CHANNEL, 2018-2030 (USD MILLION)
- TABLE 90. MALAYSIA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
- TABLE 91. MALAYSIA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
- TABLE 92. MALAYSIA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
- TABLE 93. MALAYSIA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY ROUTE, 2018-2030 (USD MILLION)
- TABLE 94. MALAYSIA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY DISTRUBUTION CHANNEL, 2018-2030 (USD MILLION)
- TABLE 95. PHILIPPINES INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
- TABLE 96. PHILIPPINES INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
- TABLE 97. PHILIPPINES INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
- TABLE 98. PHILIPPINES INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY ROUTE, 2018-2030 (USD MILLION)
- TABLE 99. PHILIPPINES INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY DISTRUBUTION CHANNEL, 2018-2030 (USD MILLION)
- TABLE 100. SINGAPORE INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
- TABLE 101. SINGAPORE INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
- TABLE 102. SINGAPORE INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
- TABLE 103. SINGAPORE INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY ROUTE, 2018-2030 (USD MILLION)
- TABLE 104. SINGAPORE INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY DISTRUBUTION CHANNEL, 2018-2030 (USD MILLION)
- TABLE 105. SOUTH KOREA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
- TABLE 106. SOUTH KOREA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
- TABLE 107. SOUTH KOREA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
- TABLE 108. SOUTH KOREA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY ROUTE, 2018-2030 (USD MILLION)
- TABLE 109. SOUTH KOREA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY DISTRUBUTION CHANNEL, 2018-2030 (USD MILLION)
- TABLE 110. TAIWAN INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
- TABLE 111. TAIWAN INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
- TABLE 112. TAIWAN INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
- TABLE 113. TAIWAN INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY ROUTE, 2018-2030 (USD MILLION)
- TABLE 114. TAIWAN INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY DISTRUBUTION CHANNEL, 2018-2030 (USD MILLION)
- TABLE 115. THAILAND INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
- TABLE 116. THAILAND INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
- TABLE 117. THAILAND INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
- TABLE 118. THAILAND INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY ROUTE, 2018-2030 (USD MILLION)
- TABLE 119. THAILAND INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY DISTRUBUTION CHANNEL, 2018-2030 (USD MILLION)
- TABLE 120. VIETNAM INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
- TABLE 121. VIETNAM INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
- TABLE 122. VIETNAM INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
- TABLE 123. VIETNAM INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY ROUTE, 2018-2030 (USD MILLION)
- TABLE 124. VIETNAM INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY DISTRUBUTION CHANNEL, 2018-2030 (USD MILLION)
- TABLE 125. EUROPE, MIDDLE EAST & AFRICA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
- TABLE 126. EUROPE, MIDDLE EAST & AFRICA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
- TABLE 127. EUROPE, MIDDLE EAST & AFRICA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
- TABLE 128. EUROPE, MIDDLE EAST & AFRICA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
- TABLE 129. EUROPE, MIDDLE EAST & AFRICA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY ROUTE, 2018-2030 (USD MILLION)
- TABLE 130. EUROPE, MIDDLE EAST & AFRICA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY DISTRUBUTION CHANNEL, 2018-2030 (USD MILLION)
- TABLE 131. DENMARK INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
- TABLE 132. DENMARK INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
- TABLE 133. DENMARK INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
- TABLE 134. DENMARK INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY ROUTE, 2018-2030 (USD MILLION)
- TABLE 135. DENMARK INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY DISTRUBUTION CHANNEL, 2018-2030 (USD MILLION)
- TABLE 136. EGYPT INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
- TABLE 137. EGYPT INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
- TABLE 138. EGYPT INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
- TABLE 139. EGYPT INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY ROUTE, 2018-2030 (USD MILLION)
- TABLE 140. EGYPT INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY DISTRUBUTION CHANNEL, 2018-2030 (USD MILLION)
- TABLE 141. FINLAND INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
- TABLE 142. FINLAND INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
- TABLE 143. FINLAND INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
- TABLE 144. FINLAND INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY ROUTE, 2018-2030 (USD MILLION)
- TABLE 145. FINLAND INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY DISTRUBUTION CHANNEL, 2018-2030 (USD MILLION)
- TABLE 146. FRANCE INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
- TABLE 147. FRANCE INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
- TABLE 148. FRANCE INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
- TABLE 149. FRANCE INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY ROUTE, 2018-2030 (USD MILLION)
- TABLE 150. FRANCE INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY DISTRUBUTION CHANNEL, 2018-2030 (USD MILLION)
- TABLE 151. GERMANY INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
- TABLE 152. GERMANY INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
- TABLE 153. GERMANY INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
- TABLE 154. GERMANY INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY ROUTE, 2018-2030 (USD MILLION)
- TABLE 155. GERMANY INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY DISTRUBUTION CHANNEL, 2018-2030 (USD MILLION)
- TABLE 156. ISRAEL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
- TABLE 157. ISRAEL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
- TABLE 158. ISRAEL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
- TABLE 159. ISRAEL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY ROUTE, 2018-2030 (USD MILLION)
- TABLE 160. ISRAEL INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY DISTRUBUTION CHANNEL, 2018-2030 (USD MILLION)
- TABLE 161. ITALY INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
- TABLE 162. ITALY INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
- TABLE 163. ITALY INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
- TABLE 164. ITALY INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY ROUTE, 2018-2030 (USD MILLION)
- TABLE 165. ITALY INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY DISTRUBUTION CHANNEL, 2018-2030 (USD MILLION)
- TABLE 166. NETHERLANDS INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
- TABLE 167. NETHERLANDS INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
- TABLE 168. NETHERLANDS INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
- TABLE 169. NETHERLANDS INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY ROUTE, 2018-2030 (USD MILLION)
- TABLE 170. NETHERLANDS INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY DISTRUBUTION CHANNEL, 2018-2030 (USD MILLION)
- TABLE 171. NIGERIA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
- TABLE 172. NIGERIA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
- TABLE 173. NIGERIA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
- TABLE 174. NIGERIA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY ROUTE, 2018-2030 (USD MILLION)
- TABLE 175. NIGERIA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY DISTRUBUTION CHANNEL, 2018-2030 (USD MILLION)
- TABLE 176. NORWAY INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
- TABLE 177. NORWAY INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
- TABLE 178. NORWAY INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
- TABLE 179. NORWAY INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY ROUTE, 2018-2030 (USD MILLION)
- TABLE 180. NORWAY INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY DISTRUBUTION CHANNEL, 2018-2030 (USD MILLION)
- TABLE 181. POLAND INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
- TABLE 182. POLAND INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
- TABLE 183. POLAND INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
- TABLE 184. POLAND INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY ROUTE, 2018-2030 (USD MILLION)
- TABLE 185. POLAND INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY DISTRUBUTION CHANNEL, 2018-2030 (USD MILLION)
- TABLE 186. QATAR INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
- TABLE 187. QATAR INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
- TABLE 188. QATAR INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
- TABLE 189. QATAR INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY ROUTE, 2018-2030 (USD MILLION)
- TABLE 190. QATAR INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY DISTRUBUTION CHANNEL, 2018-2030 (USD MILLION)
- TABLE 191. RUSSIA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
- TABLE 192. RUSSIA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
- TABLE 193. RUSSIA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
- TABLE 194. RUSSIA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY ROUTE, 2018-2030 (USD MILLION)
- TABLE 195. RUSSIA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY DISTRUBUTION CHANNEL, 2018-2030 (USD MILLION)
- TABLE 196. SAUDI ARABIA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
- TABLE 197. SAUDI ARABIA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
- TABLE 198. SAUDI ARABIA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
- TABLE 199. SAUDI ARABIA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY ROUTE, 2018-2030 (USD MILLION)
- TABLE 200. SAUDI ARABIA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY DISTRUBUTION CHANNEL, 2018-2030 (USD MILLION)
- TABLE 201. SOUTH AFRICA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
- TABLE 202. SOUTH AFRICA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
- TABLE 203. SOUTH AFRICA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
- TABLE 204. SOUTH AFRICA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY ROUTE, 2018-2030 (USD MILLION)
- TABLE 205. SOUTH AFRICA INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY DISTRUBUTION CHANNEL, 2018-2030 (USD MILLION)
- TABLE 206. SPAIN INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
- TABLE 207. SPAIN INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
- TABLE 208. SPAIN INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
- TABLE 209. SPAIN INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY ROUTE, 2018-2030 (USD MILLION)
- TABLE 210. SPAIN INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY DISTRUBUTION CHANNEL, 2018-2030 (USD MILLION)
- TABLE 211. SWEDEN INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
- TABLE 212. SWEDEN INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
- TABLE 213. SWEDEN INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
- TABLE 214. SWEDEN INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY ROUTE, 2018-2030 (USD MILLION)
- TABLE 215. SWEDEN INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY DISTRUBUTION CHANNEL, 2018-2030 (USD MILLION)
- TABLE 216. SWITZERLAND INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
- TABLE 217. SWITZERLAND INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
- TABLE 218. SWITZERLAND INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
- TABLE 219. SWITZERLAND INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY ROUTE, 2018-2030 (USD MILLION)
- TABLE 220. SWITZERLAND INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY DISTRUBUTION CHANNEL, 2018-2030 (USD MILLION)
- TABLE 221. TURKEY INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
- TABLE 222. TURKEY INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
- TABLE 223. TURKEY INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
- TABLE 224. TURKEY INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY ROUTE, 2018-2030 (USD MILLION)
- TABLE 225. TURKEY INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY DISTRUBUTION CHANNEL, 2018-2030 (USD MILLION)
- TABLE 226. UNITED ARAB EMIRATES INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
- TABLE 227. UNITED ARAB EMIRATES INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
- TABLE 228. UNITED ARAB EMIRATES INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
- TABLE 229. UNITED ARAB EMIRATES INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY ROUTE, 2018-2030 (USD MILLION)
- TABLE 230. UNITED ARAB EMIRATES INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY DISTRUBUTION CHANNEL, 2018-2030 (USD MILLION)
- TABLE 231. UNITED KINGDOM INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
- TABLE 232. UNITED KINGDOM INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
- TABLE 233. UNITED KINGDOM INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
- TABLE 234. UNITED KINGDOM INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY ROUTE, 2018-2030 (USD MILLION)
- TABLE 235. UNITED KINGDOM INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SIZE, BY DISTRUBUTION CHANNEL, 2018-2030 (USD MILLION)
- TABLE 236. INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET, FPNV POSITIONING MATRIX, 2022
- TABLE 237. INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET SHARE, BY KEY PLAYER, 2022
- TABLE 238. INHALATION & NASAL SPRAYS GENERIC DRUGS MARKET LICENSE & PRICING
目次
Product Code: MRR-032A67D91429
The Global Inhalation & Nasal Sprays Generic Drugs Market is forecasted to grow significantly, with a projected USD 8,090.64 million in 2023 at a CAGR of 8.60% and expected to reach a staggering USD 14,432.72 million by 2030.
The the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Inhalation & Nasal Sprays Generic Drugs Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.
Market Segmentation & Coverage:
This research report categorizes the Global Inhalation & Nasal Sprays Generic Drugs Market in order to forecast the revenues and analyze trends in each of following sub-markets:
Based on Indication, market is studied across Allergic Rhinitis, Asthma, and COPD. The Asthma commanded largest market share of 42.41% in 2022, followed by COPD.
Based on Age Group, market is studied across Adults, Children 2 to 5, and Children 6 to 12. The Adults commanded largest market share of 69.02% in 2022, followed by Children 6 to 12.
Based on Class, market is studied across Allergy Blocker, Anticholinergic, Antihistamine, Decongestant, Mast Cell Inhibitor, and Nasal Steroid. The Anticholinergic commanded largest market share of 22.96% in 2022, followed by Antihistamine.
Based on Route, market is studied across Inhalation, Nasal Spray, and Tropical Lotion. The Inhalation commanded largest market share of 56.04% in 2022, followed by Tropical Lotion.
Based on Distrubution Channel, market is studied across Hospital Medical Store, Online Pharmacy, and Pharmacy Retail. The Pharmacy Retail commanded largest market share of 43.55% in 2022, followed by Hospital Medical Store.
Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Europe, Middle East & Africa commanded largest market share of 41.67% in 2022, followed by Americas.
Market Statistics:
The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix is essential for assessing the Global Inhalation & Nasal Sprays Generic Drugs Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).
Market Share Analysis:
The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Market Trends: Provides comprehensive understanding of the the Russia-Ukraine Conflict, and the High Inflation
5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Inhalation & Nasal Sprays Generic Drugs Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Inhalation & Nasal Sprays Generic Drugs Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Inhalation & Nasal Sprays Generic Drugs Market?
4. What is the competitive strategic window for opportunities in the Global Inhalation & Nasal Sprays Generic Drugs Market?
5. What are the technology trends and regulatory frameworks in the Global Inhalation & Nasal Sprays Generic Drugs Market?
6. What is the market share of the leading vendors in the Global Inhalation & Nasal Sprays Generic Drugs Market?
7. What modes and strategic moves are considered suitable for entering the Global Inhalation & Nasal Sprays Generic Drugs Market?
Table of Contents
1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Limitations
- 1.7. Assumptions
- 1.8. Stakeholders
2. Research Methodology
- 2.1. Define: Research Objective
- 2.2. Determine: Research Design
- 2.3. Prepare: Research Instrument
- 2.4. Collect: Data Source
- 2.5. Analyze: Data Interpretation
- 2.6. Formulate: Data Verification
- 2.7. Publish: Research Report
- 2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
- 4.1. Introduction
- 4.2. Inhalation & Nasal Sprays Generic Drugs Market, by Indication, 2022 vs 2030
- 4.3. Inhalation & Nasal Sprays Generic Drugs Market, by Age Group, 2022 vs 2030
- 4.4. Inhalation & Nasal Sprays Generic Drugs Market, by Class, 2022 vs 2030
- 4.5. Inhalation & Nasal Sprays Generic Drugs Market, by Route, 2022 vs 2030
- 4.6. Inhalation & Nasal Sprays Generic Drugs Market, by Distrubution Channel, 2022 vs 2030
- 4.7. Inhalation & Nasal Sprays Generic Drugs Market, by Region, 2022 vs 2030
5. Market Insights
- 5.1. Market Dynamics
- 5.1.1. Drivers
- 5.1.1.1. Low Cost Involved with Generic Prescription Drugs
- 5.1.1.2. Increasing Prevalence of Respiratory Diseases
- 5.1.1.3. Significant Adoption of Nebulizers for Children
- 5.1.2. Restraints
- 5.1.2.1. Stringent Regulations For Generic Drugs
- 5.1.3. Opportunities
- 5.1.3.1. Patent Expiry of Blockbuster Drugs and Increasing FDA Approvals
- 5.1.3.2. Growing Investments from Pharmaceutical Companies for R&D
- 5.1.4. Challenges
- 5.1.4.1. Pricing Pressure due to Presence of Multiple Players in the Segment
- 5.1.1. Drivers
- 5.2. Market Trends
- 5.3. Cumulative Impact of COVID-19
- 5.4. Cumulative Impact of Russia-Ukraine Conflict
- 5.5. Cumulative Impact of High Inflation
- 5.6. Porter's Five Forces Analysis
- 5.6.1. Threat of New Entrants
- 5.6.2. Threat of Substitutes
- 5.6.3. Bargaining Power of Customers
- 5.6.4. Bargaining Power of Suppliers
- 5.6.5. Industry Rivalry
- 5.7. Value Chain & Critical Path Analysis
- 5.8. Regulatory Framework
- 5.9. Client Customization
- 5.9.1. Changing Formulation & Delivery Device
6. Inhalation & Nasal Sprays Generic Drugs Market, by Indication
- 6.1. Introduction
- 6.2. Allergic Rhinitis
- 6.3. Asthma
- 6.4. COPD
7. Inhalation & Nasal Sprays Generic Drugs Market, by Age Group
- 7.1. Introduction
- 7.2. Adults
- 7.3. Children 2 to 5
- 7.4. Children 6 to 12
8. Inhalation & Nasal Sprays Generic Drugs Market, by Class
- 8.1. Introduction
- 8.2. Allergy Blocker
- 8.3. Anticholinergic
- 8.4. Antihistamine
- 8.5. Decongestant
- 8.6. Mast Cell Inhibitor
- 8.7. Nasal Steroid
9. Inhalation & Nasal Sprays Generic Drugs Market, by Route
- 9.1. Introduction
- 9.2. Inhalation
- 9.3. Nasal Spray
- 9.4. Tropical Lotion
10. Inhalation & Nasal Sprays Generic Drugs Market, by Distrubution Channel
- 10.1. Introduction
- 10.2. Hospital Medical Store
- 10.3. Online Pharmacy
- 10.4. Pharmacy Retail
11. Americas Inhalation & Nasal Sprays Generic Drugs Market
- 11.1. Introduction
- 11.2. Argentina
- 11.3. Brazil
- 11.4. Canada
- 11.5. Mexico
- 11.6. United States
12. Asia-Pacific Inhalation & Nasal Sprays Generic Drugs Market
- 12.1. Introduction
- 12.2. Australia
- 12.3. China
- 12.4. India
- 12.5. Indonesia
- 12.6. Japan
- 12.7. Malaysia
- 12.8. Philippines
- 12.9. Singapore
- 12.10. South Korea
- 12.11. Taiwan
- 12.12. Thailand
- 12.13. Vietnam
13. Europe, Middle East & Africa Inhalation & Nasal Sprays Generic Drugs Market
- 13.1. Introduction
- 13.2. Denmark
- 13.3. Egypt
- 13.4. Finland
- 13.5. France
- 13.6. Germany
- 13.7. Israel
- 13.8. Italy
- 13.9. Netherlands
- 13.10. Nigeria
- 13.11. Norway
- 13.12. Poland
- 13.13. Qatar
- 13.14. Russia
- 13.15. Saudi Arabia
- 13.16. South Africa
- 13.17. Spain
- 13.18. Sweden
- 13.19. Switzerland
- 13.20. Turkey
- 13.21. United Arab Emirates
- 13.22. United Kingdom
14. Competitive Landscape
- 14.1. FPNV Positioning Matrix
- 14.2. Market Share Analysis, By Key Player
- 14.3. Competitive Scenario Analysis, By Key Player
15. List of Company Mentioned
16. Appendix
- 16.1. Discussion Guide
- 16.2. License & Pricing
